CoChat

Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

The cytokine interleukin (IL) 25 has been implicated in the initiation of type 2 immunity by driving the expression of type 2 cytokines such as IL-5 and IL-13, although its role in the regulation of immunity and infection-induced inflammation is unknown. Here, we identify a dual function for IL-25: first, in promoting type 2 cytokine-dependent immunity to gastrointestinal helminth infection and, second, in limiting proinflammatory cytokine production and chronic intestinal inflammation. Treatment of genetically susceptible mice with exogenous IL-25 promoted type 2 cytokine responses and immunity to Trichuris. IL-25 was constitutively expressed by CD4+ and CD8+ T cells in the gut of mouse strains that are resistant to Trichuris, and IL-25-deficient mice on a genetically resistant background failed to develop a type 2 immune response or eradicate infection. Furthermore, chronically infected IL-25(-/-) mice developed severe infection-induced intestinal inflammation associated with heightened expression of interferon-gamma and IL-17, identifying a role for IL-25 in limiting pathologic inflammation at mucosal sites. Therefore, IL-25 is not only a critical mediator of type 2 immunity, but is also required for the regulation of inflammation in the gastrointestinal tract.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20051496

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Exogenous IL-25 promotes immunity to Trichuris in genetically susceptible AKR mice. AKR mice were infected with Trichuris and treated with PBS or rIL-25 intraperitoneally every other day from days 8–18. (A) IL-25 induces a protective TH2 cytokine response. Antigen-specific IFN-γ and IL-4 production from restimulated mLN cells was determined by ELISA. White bars, medium; black bars, Trichuris antigen. (B) IL-25 promotes lymphocyte-dependent goblet cell responses. Cecal sections from day 20 infected AKR or SCID mice with or without rIL-25 treatment were stained for goblet cells. Bar, 50 μm. (C) IL-25 induces RELMβ production after infection with Trichuris. RELMβ levels were determined by immunoblotting of protein isolated from fecal pellets isolated from infected mice at days 14 and 17 after infection. (D) IL-25 promotes resistance to infection with Trichuris. Worm burdens from infected AKR or SCID mice with or without rIL-25 treatment were determined at day 20 after infection. Results are presented as mean ± SEM and are representative of three independent experiments with three to four mice per group. ND, not detected. *, P < 0.01.
Figure 1. Exogenous IL-25 promotes immunity to Trichuris in genetically susceptible AKR mice. AKR mice were infected with Trichuris and treated with PBS or rIL-25 intraperitoneally every other day from days 8–18. (A) IL-25 induces a protective TH2 cytokine response. Antigen-specific IFN-γ and IL-4 production from restimulated mLN cells was determined by ELISA. White bars, medium; black bars, Trichuris antigen. (B) IL-25 promotes lymphocyte-dependent goblet cell responses. Cecal sections from day 20 infected AKR or SCID mice with or without rIL-25 treatment were stained for goblet cells. Bar, 50 μm. (C) IL-25 induces RELMβ production after infection with Trichuris. RELMβ levels were determined by immunoblotting of protein isolated from fecal pellets isolated from infected mice at days 14 and 17 after infection. (D) IL-25 promotes resistance to infection with Trichuris. Worm burdens from infected AKR or SCID mice with or without rIL-25 treatment were determined at day 20 after infection. Results are presented as mean ± SEM and are representative of three independent experiments with three to four mice per group. ND, not detected. *, P < 0.01.CC BY-NC-SA · PubMed Central
Figure 2. IL-25 is expressed constitutively in the cecal patch of mice resistant to Trichuris. (A) Increased expression of IL-25 and IL-25R mRNA in the cecum of resistant BALB/c (B/c) mice. IL-25 and IL-25R mRNA levels were determined by real-time PCR from the cecum or mLN of naive BALB/c or AKR mice. (B) CD4+ and CD8+ T cells in the cecal patch express lacZ/IL-25. Cells from the mLN or cecal patch of IL-25−/− mice were stained with FDG and CD4 or CD8. Numbers represent frequency of FDG+ CD4+ or CD8+ T cells. Data are representative of three to four independent experiments with three to four mice per group.
Figure 2. IL-25 is expressed constitutively in the cecal patch of mice resistant to Trichuris. (A) Increased expression of IL-25 and IL-25R mRNA in the cecum of resistant BALB/c (B/c) mice. IL-25 and IL-25R mRNA levels were determined by real-time PCR from the cecum or mLN of naive BALB/c or AKR mice. (B) CD4+ and CD8+ T cells in the cecal patch express lacZ/IL-25. Cells from the mLN or cecal patch of IL-25−/− mice were stained with FDG and CD4 or CD8. Numbers represent frequency of FDG+ CD4+ or CD8+ T cells. Data are representative of three to four independent experiments with three to four mice per group.CC BY-NC-SA · PubMed Central
Figure 3. Endogenous IL-25 is required for resistance to Trichuris. (A) IL-25 is required for optimal production of TH2 cytokines after infection. IL-4, IL-13, and IFN-γ expression in the mLN and cecum in WT and IL-25−/− mice at day 18 after infection as measured by real-time PCR. (B) Defective goblet cell responses in IL-25−/− mice after infection with Trichuris. Cecal sections from day 18 infected WT or IL-25−/− mice were stained for goblet cells. Bar, 50 μm. (C) IL-25−/− mice fail to up-regulate RELMβ after infection. Protein isolated from fecal pellets on various days after infection was analyzed by SDS-PAGE and immunoblotted for RELMβ. (D) IL-25 is required for resistance to infection with Trichuris. Worm burdens in WT, IL-25−/− and RAG−/− mice at day 30 after infection. Data are presented as mean ± SEM and are representative of four independent experiments with three to four mice per group. N, naive; I, infected.
Figure 3. Endogenous IL-25 is required for resistance to Trichuris. (A) IL-25 is required for optimal production of TH2 cytokines after infection. IL-4, IL-13, and IFN-γ expression in the mLN and cecum in WT and IL-25−/− mice at day 18 after infection as measured by real-time PCR. (B) Defective goblet cell responses in IL-25−/− mice after infection with Trichuris. Cecal sections from day 18 infected WT or IL-25−/− mice were stained for goblet cells. Bar, 50 μm. (C) IL-25−/− mice fail to up-regulate RELMβ after infection. Protein isolated from fecal pellets on various days after infection was analyzed by SDS-PAGE and immunoblotted for RELMβ. (D) IL-25 is required for resistance to infection with Trichuris. Worm burdens in WT, IL-25−/− and RAG−/− mice at day 30 after infection. Data are presented as mean ± SEM and are representative of four independent experiments with three to four mice per group. N, naive; I, infected.CC BY-NC-SA · PubMed Central
Figure 4. Type 2 inflammation is IL-25 independent when endogenous type 1 responses are inhibited. Infected IL-25−/− mice were treated with anti–IL-12 and anti–IFN-γ every 4 d between days 4 and 20. (A) Blockade of type 1 cytokines in infected IL-25−/− mice recovers TH2 cytokine responses. Antigen-specific IL-4, IL-5, IL-13, and IFN-γ responses by restimulated mLN cells from control (Ig) or αIL-12/αIFN-γ–treated (α12/γ) IL-25−/− mice determined by cytometric bead array (CBA; IL-4, IL-5, and IFNγ) or ELISA (IL-13). (B) Anti–IL-12/anti–IFN-γ treatment recovers goblet cell responses in infected IL-25−/− mice. Goblet cell responses in the cecum of infected WT and control or αIL-12/αIFN-γ–treated IL-25−/− mice on day 20 after infection. Bar, 50 μm. (C) IL-25 is dispensable for resistance to infection with Trichuris when type 1 responses are neutralized. Worm burdens in infected WT and control or αIL-12/αIFN-γ–treated IL-25−/− mice were determined at day 20 after infection. Results are presented as mean ± SEM and represent two independent experiments with three to four mice per group. *, P < 0.01.
Figure 4. Type 2 inflammation is IL-25 independent when endogenous type 1 responses are inhibited. Infected IL-25−/− mice were treated with anti–IL-12 and anti–IFN-γ every 4 d between days 4 and 20. (A) Blockade of type 1 cytokines in infected IL-25−/− mice recovers TH2 cytokine responses. Antigen-specific IL-4, IL-5, IL-13, and IFN-γ responses by restimulated mLN cells from control (Ig) or αIL-12/αIFN-γ–treated (α12/γ) IL-25−/− mice determined by cytometric bead array (CBA; IL-4, IL-5, and IFNγ) or ELISA (IL-13). (B) Anti–IL-12/anti–IFN-γ treatment recovers goblet cell responses in infected IL-25−/− mice. Goblet cell responses in the cecum of infected WT and control or αIL-12/αIFN-γ–treated IL-25−/− mice on day 20 after infection. Bar, 50 μm. (C) IL-25 is dispensable for resistance to infection with Trichuris when type 1 responses are neutralized. Worm burdens in infected WT and control or αIL-12/αIFN-γ–treated IL-25−/− mice were determined at day 20 after infection. Results are presented as mean ± SEM and represent two independent experiments with three to four mice per group. *, P < 0.01.CC BY-NC-SA · PubMed Central
Figure 5. IL-25 is required to limit infection-induced intestinal inflammation. WT and IL-25−/− mice were infected with Trichuris and allowed to progress to the chronic phase of infection (day 30 after infection). (A) IL-25 is required to inhibit infection-induced pathology. Cecal sections from naive or infected (day 30) AKR, B6 WT, or IL-25−/− mice were stained with hematoxylin and eosin. Bar, 50 μm. (B and C) IL-25 limits expression of proinflammatory cytokines in the draining mLN and gut after infection with Trichuris. (B) Increased Trichuris-specific IFN-γ and IL-17 produced by mLN cells from WT or IL-25−/− mice at day 18 after infection as measured by CBA (IFN-γ) or ELISA (IL-17). White bars, medium; black bars, Trichuris antigen. (C) Expression of mRNA for IFN-γ and IL-17 in the mLN and cecum of WT and IL-25−/− mice at day 30 after infection. (D) IL-10 expression in the mLN is intact in infected IL-25−/− mice. mLN cells from WT or IL-25−/− mice at day 18 after infection were restimulated with (black bars) or without (white bars) Trichuris antigen and IL-10 levels were determined by CBA. IL-10 mRNA levels in the mLN at day 30 after infection were determined by real-time PCR. Results are presented as mean ± SEM and represent three independent experiments with three to four mice per group. ND, not detected.
Figure 5. IL-25 is required to limit infection-induced intestinal inflammation. WT and IL-25−/− mice were infected with Trichuris and allowed to progress to the chronic phase of infection (day 30 after infection). (A) IL-25 is required to inhibit infection-induced pathology. Cecal sections from naive or infected (day 30) AKR, B6 WT, or IL-25−/− mice were stained with hematoxylin and eosin. Bar, 50 μm. (B and C) IL-25 limits expression of proinflammatory cytokines in the draining mLN and gut after infection with Trichuris. (B) Increased Trichuris-specific IFN-γ and IL-17 produced by mLN cells from WT or IL-25−/− mice at day 18 after infection as measured by CBA (IFN-γ) or ELISA (IL-17). White bars, medium; black bars, Trichuris antigen. (C) Expression of mRNA for IFN-γ and IL-17 in the mLN and cecum of WT and IL-25−/− mice at day 30 after infection. (D) IL-10 expression in the mLN is intact in infected IL-25−/− mice. mLN cells from WT or IL-25−/− mice at day 18 after infection were restimulated with (black bars) or without (white bars) Trichuris antigen and IL-10 levels were determined by CBA. IL-10 mRNA levels in the mLN at day 30 after infection were determined by real-time PCR. Results are presented as mean ± SEM and represent three independent experiments with three to four mice per group. ND, not detected.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

Metadata

Authors
Owyang, A. M., Zaph, C., Wilson, E. H., Guild, K. J., McClanahan, T., Miller, H. R. P., Cua, D. J., Goldschmidt, M., Hunter, C. A., Kastelein, R. A., & Artis, D.
Affiliations
  • 2Discovery Research, Schering-Plough Biopharma, Palo Alto, CA 94304
  • University of Pennsylvania (US)
  • University of Edinburgh (GB)
Venue
The Journal of Experimental Medicine
Published
2006-04-10
Volume
203
Issue
4
Pages
843-849
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2158591788
Cited by
379
References
30
Citations by year
2026: 4 · 2025: 11 · 2024: 8 · 2023: 17 · 2022: 24 · 2021: 14 · 2020: 15 · 2019: 12 · 2018: 17 · 2017: 18 · 2016: 20 · 2015: 20 · 2014: 26 · 2013: 24 · 2012: 19
FWCI
9.71
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (AI 42334, R01AI042334, R01AI061570, AI 61570)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-50306, P30DK050306)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
IL-25, Th2 immune response, type 2 cytokines, IL-5, IL-13, gastrointestinal helminth infection, Trichuris, chronic intestinal inflammation, interferon-gamma, IL-17, mucosal immunity, CD4+ T cells, CD8+ T cells, genetic susceptibility to infection
MeSH terms
Animals, Cell Differentiation, Cells, Cultured, Chronic Disease, Inflammation, Interleukins, Mice, Inbred AKR, Mice, Inbred C57BL, Recombinant Proteins, Trichuriasis, Trichuris, Cytokines, Mice, SCID, Mice, Knockout, Th1 Cells, Gastrointestinal Tract, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.